Lukas Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	34.75	64.71	31.8	40.26	64.81
Cash & Short-Term Investments	34.75	64.71	31.8	40.26	64.81
Cash Growth	-46.31%	103.50%	-21.02%	-37.88%	66.00%
Accounts Receivable	11.52	9.68	10.68	12.09	18.25
Receivables	11.52	9.68	10.68	12.09	18.25
Inventory	35.39	38.02	36.73	42.4	26.89
Prepaid Expenses	9.15	10.55	6.32	9.84	9.91
Other Current Assets	1.53	1.53	1.85	0.94	0.66
Total Current Assets	92.33	124.5	87.37	105.53	120.53
Property, Plant & Equipment	50.49	72.52	75.47	92.89	123.51
Other Intangible Assets	0.27	-	0.03	0.09	0.2
Long-Term Deferred Tax Assets	-	1.87	1.77	1.85	2
Other Long-Term Assets	283.71	277.62	276.55	279.31	285
Total Assets	426.8	476.5	441.19	479.67	531.24
Accounts Payable	4.11	5.71	6.95	8.99	3.18
Accrued Expenses	-	14.63	-	-	-
Short-Term Debt	65	-	5	-	90
Current Portion of Long-Term Debt	11.73	11.44	7.65	6.37	6.39
Current Portion of Leases	11.07	13.53	13.38	12.64	13.82
Current Unearned Revenue	1.04	1.58	1.51	11.69	1.2
Other Current Liabilities	21.87	10.04	23.16	16.77	15.95
Total Current Liabilities	114.81	56.93	57.65	56.45	130.54
Long-Term Debt	46.72	58.46	69.91	57.53	63.82
Long-Term Leases	21.51	31.77	29.93	35.69	47.27
Other Long-Term Liabilities	3.58	3.53	3.57	2.51	2.93
Total Liabilities	186.62	150.68	161.06	152.18	244.57
Common Stock	418.74	418.74	368.74	368.74	328.74
Additional Paid-In Capital	90.07	90.07	-	96.17	0.17
Retained Earnings	-268.62	-182.99	-88.61	-137.43	-87.36
Comprehensive Income & Other	-	-	-	-	45.12
Total Common Equity	240.19	325.82	280.13	327.49	286.68
Shareholders' Equity	240.19	325.82	280.13	327.49	286.68
Total Liabilities & Equity	426.8	476.5	441.19	479.67	531.24
Total Debt	156.02	115.2	125.86	112.22	221.31
Net Cash (Debt)	-121.27	-50.49	-94.06	-71.96	-156.5
Net Cash Per Share	-2.90	-1.28	-2.55	-1.96	-4.76
Filing Date Shares Outstanding	41.67	41.87	36.87	36.87	32.87
Total Common Shares Outstanding	41.67	41.87	36.87	36.87	32.87
Working Capital	-22.49	67.57	29.72	49.08	-10.01
Book Value Per Share	5.76	7.78	7.60	8.88	8.72
Tangible Book Value	239.91	325.82	280.1	327.39	286.48
Tangible Book Value Per Share	5.76	7.78	7.60	8.88	8.71
Buildings	-	28.27	28.27	28.27	28.31
Machinery	-	61.85	55.86	53.89	53.8
Leasehold Improvements	-	7.12	7.26	7.26	31.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.